| Health / Medical Topics |
CDK Inhibitor P276-00
A flavone and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. P276-00 selectively binds to and inhibits Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, serine/threonine kinases that play key roles in the regulation of the cell cycle and cellular proliferation. Inhibition of these kinases leads to cell cycle arrest during the G1/S transition, thereby leading to an induction of apoptosis, and inhibition of tumor cell proliferation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to…
The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables.
This SDTM class describes the plan for the procedures to be followed in a clinical trial, including planned and actual timing of…
Terms at the highest level of the CDISC system organ class terminology.
The Subject-Level Analysis Dataset (ADSL) is a one-record-per-subject dataset which contains variables that describe subject demographic characteristics and group the subjects for…
This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains…
